Max Healthcare Institute Limited (MAXHEALTH) — Stock Analysis

Max Healthcare Institute Limited (NSE: MAXHEALTH), ISIN INE027H01010 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.

MAXHEALTH last traded at ₹1111.25 (+0.58%), with a 52-week range of ₹903.50 to ₹1301.95 (as of 30 Jul 2026).

Shareholding as of Mar 2026: promoters 23.71%, FIIs 45.39%, DIIs 26.32%, mutual funds 16.30%.

EquiSense Score (ECS): 81/100.

Data sourced from NSE and BSE filings. Educational — not investment advice.